These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32540399)

  • 1. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
    Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
    Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive investigation of T and B cell receptor repertoires in an MC38 tumor model following murine anti‑PD‑1 administration.
    Zhang L; Wang IM; Solban N; Cristescu R; Zeng G; Long B
    Mol Med Rep; 2020 Aug; 22(2):975-985. PubMed ID: 32468004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
    Han Y; Li H; Guan Y; Huang J
    Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.
    Yoneda K; Kuwata T; Kanayama M; Mori M; Kawanami T; Yatera K; Ohguri T; Hisaoka M; Nakayama T; Tanaka F
    Br J Cancer; 2019 Sep; 121(6):490-496. PubMed ID: 31388183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
    Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
    Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of the fetus: fetal B and T cell receptor repertoire development.
    Rechavi E; Somech R
    Semin Immunopathol; 2017 Nov; 39(6):577-583. PubMed ID: 28466095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
    Mony JT; Schuchert MJ
    Front Immunol; 2018; 9():2298. PubMed ID: 30374348
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
    Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
    Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure.
    Yan Q; Wang L; Lai L; Liu S; Chen H; Zhang J; Dai Y; Sui W
    Int J Mol Med; 2019 Jan; 43(1):243-255. PubMed ID: 30365073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing the peripheral blood B and T cell repertoire - Quantifying robustness and limitations.
    Simon JS; Botero S; Simon SM
    J Immunol Methods; 2018 Dec; 463():137-147. PubMed ID: 30312601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions.
    Saini J; Hershberg U
    Mol Immunol; 2015 May; 65(1):157-67. PubMed ID: 25660968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in Blood.
    Weinberger J; Jimenez-Heredia R; Schaller S; Suessner S; Sunzenauer J; Reindl-Schwaighofer R; Weiss R; Winkler S; Gabriel C; Danzer M; Oberbauer R
    PLoS One; 2015; 10(11):e0143125. PubMed ID: 26600245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2RX7B is a new theranostic marker for lung adenocarcinoma patients.
    Benzaquen J; Dit Hreich SJ; Heeke S; Juhel T; Lalvee S; Bauwens S; Saccani S; Lenormand P; Hofman V; Butori M; Leroy S; Berthet JP; Marquette CH; Hofman P; Vouret-Craviari V
    Theranostics; 2020; 10(24):10849-10860. PubMed ID: 33042257
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.